The Comparison of anti-inflammatory versus supplement dose of selenium in mild Graves' orbitopathy
Phase 1
- Conditions
- Clinical activity scoreGraves'Quality of lifeOverall eye examinationsDisease progression
- Registration Number
- TCTR20180228005
- Lead Sponsor
- Ratchadapiseksompotch Research fund
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
-Mild thyroid eye disease group according to EUGOGO recommendation
-Age above 18 years old
-Normal thyroid hormone level (FT4, FT3) for at least 6 months
-Thyroid eye symptoms less than 24 months
Exclusion Criteria
-Allergic reaction to selenium
-History of selenium use
-Pregnant or breast-feeding
-Recent history of orbital and eyelid surgery of less than 6 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Graves clinical activity score 0,6 months EUGOGO Graves clinical activity scaling
- Secondary Outcome Measures
Name Time Method Graves' Quality of life 0,3,6 months Graves' Quality of life Questionaire